These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 16502765

  • 1. Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation.
    Sauron R, Wilkins M, Jessent V, Dubois A, Maillot C, Weil A.
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):64-70. PubMed ID: 16502765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics.
    Jones MR, Baker BA, Mathew P.
    Clin Pharmacokinet; 2004 Feb; 43(13):943-50. PubMed ID: 15509187
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.
    Yun HY, Joo Lee E, Youn Chung S, Choi SO, Kee Kim H, Kwon JT, Kang W, Kwon KI.
    Clin Pharmacokinet; 2006 Feb; 45(4):425-32. PubMed ID: 16584288
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of pharmacokinetics of two fenofibrate tablet formulations in healthy human subjects.
    Chachad SS, Gole M, Malhotra G, Naidu R.
    Clin Ther; 2014 Jun 01; 36(6):967-73. PubMed ID: 24844853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomised crossover studies of the bioequivalence of two fenofibrate formulations after administration of a single oral dose in healthy volunteers.
    Sonet B, Vanderbist F, Streel B, Houin G.
    Arzneimittelforschung; 2002 Jun 01; 52(3):200-4. PubMed ID: 11963648
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
    Kim KS, Kim JH, Jin SG, Kim DW, Kim DS, Kim JO, Yong CS, Cho KH, Li DX, Woo JS, Choi HG.
    Arch Pharm Res; 2016 Apr 01; 39(4):531-538. PubMed ID: 26992922
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K, Lamson M, Salageanu J, Bramson C, Matschke K, Malhotra B.
    Clin Pharmacol Drug Dev; 2015 Sep 01; 4(5):370-6. PubMed ID: 27137146
    [Abstract] [Full Text] [Related]

  • 19. A mechanism-based pharmacokinetic model of fenofibrate for explaining increased drug absorption after food consumption.
    Back HM, Song B, Pradhan S, Chae JW, Han N, Kang W, Chang MJ, Zheng J, Kwon KI, Karlsson MO, Yun HY.
    BMC Pharmacol Toxicol; 2018 Jan 25; 19(1):4. PubMed ID: 29370865
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.